Target intelligence / Profile preview

Activity-dependent neuroprotective protein–End-binding protein complex (ADNP–EB1/EB3 complex)

Target
ADNP–EB1/EB3 complex
Molecular classification
Protein complex, Microtubule-associated protein complex, Transcription factor complex
01

Overview

The Activity-dependent neuroprotective protein (ADNP)–End-binding protein (EB) complex is a vital protein-protein interaction assembly that regulates microtubule dynamics and stability in neurons. ADNP, a protein essential for brain development, contains a SIP (Ser-Ile-Pro) motif—a variant of the SxIP motif—which mediates its binding to the C-terminal domains of EB1 and EB3 proteins at the plus-ends of microtubules (Oz et al., 2014; Ivashko-Pachima et al., 2017). This interaction is fundamental for axonal transport, dendritic spine density, and overall synaptic plasticity. Disruptions in this complex are linked to neurodegenerative conditions like Alzheimer's disease and neurodevelopmental disorders such as ADNP syndrome (Helsmoortel-Van der Aa syndrome), which is characterized by autism and intellectual disability (Helsmoortel et al., 2014; Gozes, 2011). The therapeutic peptide Davunetide (NAP) is derived from ADNP and contains the SIP motif, allowing it to mimic and stabilize the ADNP-EB interaction. By promoting microtubule-dependent transport and protecting against microtubule disassembly, this complex serves as a key target for neuroprotective interventions (Gozes et al., 2014).

Other names
ADNP-EB1 complexADNP-EB3 complexADNP-EB interactionADNP SxIP motifNAP-EB interaction
02

Mechanism of action

Stabilization of the ADNP-EB interaction to enhance microtubule dynamics and protect against tau-related pathology.

03

Biological functions

Microtubule dynamicsAxonal transportSynaptic plasticityNeuroprotectionNeurite outgrowthDendritic spine formation
04

Disease associations

Alzheimer's diseaseADNP syndrome (Helsmoortel-Van der Aa syndrome)Autism spectrum disorderSchizophreniaFrontotemporal dementiaParkinson's disease
05

Safety considerations

Microtubule over-stabilizationOff-target effects on cell divisionTherapeutic efficacy in late-stage neurodegeneration
06

Interacting drugs

Davunetide

3 more in the full profile.

07

Biomarkers

ADNP mRNA levelsADNP protein levels in plasmaEB1/EB3 expression levelsMicrotubule stability markers

Beyond the preview

Go deeper on Activity-dependent neuroprotective protein–End-binding protein complex (ADNP–EB1/EB3 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Activity-dependent neuroprotective protein–End-binding protein complex (ADNP–EB1/EB3 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call